Showing results (51-60 of 59) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 59 results.
Kidney International Reports|November 29, 2023
Humoral and Cellular Immunogenicity of 3 Doses of BNT162b2 in Children With Kidney DiseasesDaniel Leung, Eugene Yu-Hin Chan, Xiaofeng Mu, et al.
Nature Communications|June 28, 2022
Immunogenicity and reactogenicity of SARS-CoV-2 vaccines BNT162b2 and CoronaVac in healthy adolescentsJaime S Rosa Duque, Xiwei Wang, Daniel Leung, et al.
Signal Transduction and Targeted Therapy|December 14, 2022
Antibody and T cell responses against wild-type and Omicron SARS-CoV-2 after third-dose BNT162b2 in adolescentsXiaofeng Mu, Carolyn A Cohen, Daniel Leung, et al.
Frontiers in Immunology|October 7, 2022
Safety and immunogenicity of 3 doses of BNT162b2 and CoronaVac in children and adults with inborn errors of immunityDaniel Leung, Xiaofeng Mu, Jaime S Rosa Duque, et al.
World Journal of Pediatrics : WJP|December 12, 2023
Superior antibody and membrane protein-specific T-cell responses to CoronaVac by intradermal versus intramuscular routes in adolescentsJaime S Rosa Duque, Samuel M S Cheng, Carolyn A Cohen, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 16, 2024
SARS-CoV-2-specific CD8<sup>+</sup> T cells from people with long COVID establish and maintain effector phenotype and key TCR signatures over 2 yearsLouise C Rowntree, Jennifer Audsley, Lilith F Allen, et al.
Viruses|January 8, 2025
A Global Collaborative Comparison of SARS-CoV-2 Antigenicity Across 15 LaboratoriesPolina Brangel, Sina Tureli, Barbara Mühlemann, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 2, 2025
HLA-B*15:01-positive severe COVID-19 patients lack CD8<sup>+</sup> T cell pools with highly expanded public clonotypesLouise C Rowntree, Lilith F Allen, Ruth R Hagen, et al.
Pageof 6